Tinea Pedis Treatment Market

Tinea Pedis Treatment Market: Vesicular Tinea Pedis Disease Type Segment to Reflect a High Growth Rate During the Forecast Period: Global Industry Analysis (2012 - 2016) and Opportunity Assessment (2017 - 2027)

Ask The Analyst Customization Available Request Methodology

Focus of government on prevention of diseases to curb healthcare costs; entry into untapped markets to present opportunities for growth

Tinea infections are fungal infections caused by T rubrum, Trichophyton mentagrophytes and Epidermophyton floccosum. This dermatophyte fungus thrives in humid conditions. The clinical features of tinea pedis include patchy and dry scaling on foot and presence of blisters or pustules on feet and between toes. Various countries are focusing on prevention of microbial and fungal diseases to reduce their healthcare costs, which in turn, is expected to result in high demand for advanced treatment options and diagnostic processes from local governments and third-party payers.

Moreover, increasing research and development activities to develop highly specific antifungal products are also expected to create new growth opportunities for manufacturers operating in tinea pedis treatment market. Currently, several countries are still unaware about fungal treatment. In several low income countries, physicians depend on antibacterial treatment and steroids for the treatment process. Awareness about effective treatment procedures in these countries is very low. However, these countries have a large patient pool and hence, various companies are trying to enter into these markets by offering better quality and affordable antifungal products.

Insights on the global tinea pedis treatment market

Future Market Insights in its research report on the global tinea pedis treatment market has described a complete market scenario and has presented forecast insights on the global market for tinea pedis treatment for a period of 10 years. According to Future Market Insights, the global tinea pedis treatment market is expected to grow at a moderate rate to register a CAGR of 4.8% throughout the period of forecast, 2017-2027. The estimation value of global tinea pedis treatment market is bit more than US$ 1 Bn in 2017 and is anticipated to touch a value more than US$ 1700 Mn by the end of 2027. The growth of the global tinea pedis treatment market can be attributed towards increasing geriatric population, rising consumer inclination towards maintaining aesthetic appearance, increasing product innovation and rising per capita healthcare expenditure.

Increasing occurrence of interdigital tinea pedis to augment the demand for the treatment of the disease in the coming years

Typically, tinea pedis occurs in the form of interdigital spaces. The occurrence of interdigital tinea pedis is higher than other type of tinea pedis diseases. This has led to an increased focus on the treatment of interdigital tinea pedis. The interdigital tinea pedis segment in the disease type category is the largest segment owing to higher prevalence of the disease. The interdigital tinea pedis segment is expected to grow at a CAGR of 4.5% throughout the period of forecast and is expected to generate a value of more than US$ 1.1 Bn by the end of 2027. In 2017, it is valued at less than US$ 750 Mn. This segment is expected to dominate the global market by disease type.

tinea-pedis-treatment-market.jpg

Plantar tinea pedis, also known as moccasin foot, occurs on the side of the foot. The plantar tinea pedis segment is anticipated to grow at a significant rate to reach an estimation of around US$ 320 Mn by the end of the year of assessment. This is the second largest segment in terms of value as well as growth rate. It is projected to register a CAGR of 5.1% during the period of forecast, 2017-2027.

Description of the research supporting your decision in investing in the report

The extensive research report titled “Tinea Pedis Treatment Market: Global Industry Analysis (2012-2016) and Opportunity Assessment (2017-2027)” crafted by Future Market Insights assists the reader in compiling and slating key growth strategies with a view to maintain correct growth rhythm in spite of the changing market dynamics in the current as well as in the future. Analysis on each segment of the market is included and assessment of these segments across key region in the globe is presented in a methodical format in the report.

The research reflects the global market view in a nutshell

The research report on tinea pedis treatment market covers various trends, opportunities, developments, drivers and restraints influencing the growth of the global market. These aspects are studied across key regional markets and their intensity is assessed from which the current and future market scenario is gauged. The statistics and data supporting these predictions are arranged in an orderly manner convenient for the reader to use. All the statistics are obtained keeping an unbiased view into consideration thus emphasizing on the authenticity of the research report. Moreover, deep diving in the segments along with a strong data mining process enables to sketch the possible future market direction and a complete scenario of the global tinea pedis treatment market with valuable acumen to offer need based solutions. The research on the global tinea pedis treatment market is carried out keeping a predefined purpose having clarity about the market, and involves appropriate statistical data based on a clear market definition.

The research follows a strong research methodology

Primary research and secondary research are used to glean relevant insights of the global tinea pedis treatment market. The research process includes several funnels of validation of the data to take the numbers to almost 100 percent accuracy. The data point associated with each segment is cross verified during every level of the primary research. Additionally, opinions from subject matter experts and market observers is also collated and with the help of triangulation method, data pertaining to respective market segments is obtained that radiates high precision.

In-depth five level market segmentation

The research report on global tinea pedis treatment market covers an in-depth market segmentation that covers every angle of the market.

By Disease Type

By Drug Class

By Route of Administration

By Distribution Channel

By Region

  • Interdigital Tinea Pedis

  • Plantar Tinea Pedis

  • Vesicular Tinea Pedis

  • Antifungals

  • Steroids and Anti-Infective Combinations

  • Topical

    • Gel

    • Cream

    • Spray

    • Lotion

    • Powder

  • Oral

  • Hospital Pharmacies

  • Retail Pharmacies

  • Drug Stores

  • Online Pharmacies

  • North America

  • Latin America

  • Western Europe

  • Eastern Europe

  • Asia Pacific excluding Japan (APEJ)

  • Japan

  • Middle East and Africa (MEA)

 

The report covers weighted analysis of the competition scenario

The research report also includes a separate section focusing on the key players within the market. This section, called competitive analysis, uncovers all the major facts about the key companies involved in the activities pertaining to the global tinea pedis treatment market. Their product portfolio analysis, pricing strategies, marketing strategies, promotion tactics, expansion plans, regional spread, major developments and key innovations, mergers and acquisitions, important strategies, revenue, market shares, key personnel, other key financials etc., is included in this report that can give the reader a broad idea about the activities in the market based on which next moves can be planned. The companies included in this section are those which have enormous hold on the market and studying their tactics can definitely help the upcoming players to move up the ladder accomplishing their respective milestones.

Tinea Pedis Treatment Market Reports - Table of Contents

1. Executive Summary

1.1. Overview

1.2. Market Analysis

1.3. FMI Analysis and Recommendations

1.4. Wheel of Fortune

2. Market Introduction

2.1. Market Taxonomy

2.2. Market Definition

3. Tinea Pedis Treatment Market View Point 

3.1. Macro-Economic Factors

3.2. Opportunity Analysis

3.3. Incidence of Tinea Pedis

3.4. Regulatory Scenario

3.5. Pricing Analysis

4. North America Tinea Pedis Treatment Market Analysis 2012–2016 and Forecast 2017–2027

4.1. Introduction

4.2. Regional Market Dynamics

4.2.1. Drivers

4.2.2. Restraints

4.2.3. Trends

4.3. Historical Market Size (US$ Mn) Analysis By Country, 2012–2016

4.3.1. U.S.

4.3.2. Canada

4.4. Market Size (US$ Mn) Forecast By Country, 2017–2027

4.4.1. U.S.

4.4.2. Canada

4.5. Historical Market Size (US$ Mn) Analysis By Disease Type, 2012-2016

4.5.1. Interdigital Tinea Pedis

4.5.2. Plantar Tinea Pedis

4.5.3. Vesicular Tinea Pedis

4.6. Market Size (US$ Mn) Forecast By Disease Type, 2017-2027

4.6.1. Interdigital Tinea Pedis

4.6.2. Plantar Tinea Pedis

4.6.3. Vesicular Tinea Pedis

4.7. Historical Market Size (US$ Mn) Analysis By Drug Class, 2012-2016

4.7.1. Antifungals

4.7.2. Steroids and Anti-Infective Combinations

4.8. Market Size (US$ Mn) Forecast By Drug Class, 2017-2027

4.8.1. Antifungals

4.8.2. Steroids and Anti-Infective Combinations

4.9. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2012-2016

4.9.1. Topical

4.9.1.1. Gel

4.9.1.2. Cream

4.9.1.3. Spray

4.9.1.4. Lotion

4.9.1.5. Powder

4.9.2. Oral

4.10. Market Size (US$ Mn) Forecast By Route of Administration, 2017-2027

4.10.1. Topical

4.10.1.1. Gel

4.10.1.2. Cream

4.10.1.3. Spray

4.10.1.4. Lotion

4.10.1.5. Powder

4.10.2. Oral

4.11. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012-2016

4.11.1. Hospital Pharmacies

4.11.2. Retail Pharmacies

4.11.3. Drug Stores

4.11.4. Online Pharmacies

4.12. Market Size (US$ Mn) Forecast By Distribution Channel, 2017-2027

4.12.1. Hospital Pharmacies

4.12.2. Retail Pharmacies

4.12.3. Drug Stores

4.12.4. Online Pharmacies

4.13. Drivers and Restraints: Impact Analysis

4.14. Market Attractiveness Analysis

4.14.1. By Country

4.14.2. By Disease Type

4.14.3. By Drug Class

4.14.4. By Route of Administration

4.14.5. By Distribution Channel

5. Latin America Tinea Pedis Treatment Market Analysis 2012–2016 and Forecast 2017–2027

5.1. Introduction

5.2. Regional Market Dynamics

5.2.1. Drivers

5.2.2. Restraints

5.2.3. Trends

5.3. Historical Market Size (US$ Mn) Analysis By Country, 2012–2016

5.3.1. Brazil

5.3.2. Mexico

5.3.3. Rest of Latin America

5.4. Market Size (US$ Mn) Forecast By Country, 2017–2027

5.4.1. Brazil

5.4.2. Mexico

5.4.3. Rest of Latin America

5.5. Historical Market Size (US$ Mn) Analysis By Disease Type, 2012-2016

5.5.1. Interdigital Tinea Pedis

5.5.2. Plantar Tinea Pedis

5.5.3. Vesicular Tinea Pedis

5.6. Market Size (US$ Mn) Forecast By Disease Type, 2017-2027

5.6.1. Interdigital Tinea Pedis

5.6.2. Plantar Tinea Pedis

5.6.3. Vesicular Tinea Pedis

5.7. Historical Market Size (US$ Mn) Analysis By Drug Class, 2012-2016

5.7.1. Antifungals

5.7.2. Steroids and Anti-Infective Combinations

5.8. Market Size (US$ Mn) Forecast By Drug Class, 2017-2027

5.8.1. Antifungals

5.8.2. Steroids and Anti-Infective Combinations

5.9. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2012-2016

5.9.1. Topical

5.9.1.1. Gel

5.9.1.2. Cream

5.9.1.3. Spray

5.9.1.4. Lotion

5.9.1.5. Powder

5.9.2. Oral

5.10. Market Size (US$ Mn) Forecast By Route of Administration, 2017-2027

5.10.1. Topical

5.10.1.1. Gel

5.10.1.2. Cream

5.10.1.3. Spray

5.10.1.4. Lotion

5.10.1.5. Powder

5.10.2. Oral

5.11. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012-2016

5.11.1. Hospital Pharmacies

5.11.2. Retail Pharmacies

5.11.3. Drug Stores

5.11.4. Online Pharmacies

5.12. Market Size (US$ Mn) Forecast By Distribution Channel, 2017-2027

5.12.1. Hospital Pharmacies

5.12.2. Retail Pharmacies

5.12.3. Drug Stores

5.12.4. Online Pharmacies

5.13. Drivers and Restraints: Impact Analysis

5.14. Market Attractiveness Analysis

5.14.1. By Country

5.14.2. By Disease Type

5.14.3. By Drug Class

5.14.4. By Route of Administration

5.14.5. By Distribution Channel

6. Western Europe Tinea Pedis Treatment Market Analysis 2012–2016 and Forecast 2017–2027

6.1. Introduction

6.2. Regional Market Dynamics

6.2.1. Drivers

6.2.2. Restraints

6.2.3. Trends

6.3. Historical Market Size (US$ Mn) Analysis By Country, 2012–2016

6.3.1. Germany

6.3.2. Italy

6.3.3. France

6.3.4. Spain

6.3.5. U.K.

6.3.6. BENELUX

6.3.7. Nordic

6.3.8. Rest of Western Europe

6.4. Market Size (US$ Mn) Forecast By Country, 2017–2027

6.4.1. Germany

6.4.2. Italy

6.4.3. France

6.4.4. Spain

6.4.5. U.K.

6.4.6. BENELUX

6.4.7. Nordic

6.4.8. Rest of Western Europe

6.5. Historical Market Size (US$ Mn) Analysis By Disease Type, 2012-2016

6.5.1. Interdigital Tinea Pedis

6.5.2. Plantar Tinea Pedis

6.5.3. Vesicular Tinea Pedis

6.6. Market Size (US$ Mn) Forecast By Disease Type, 2017-2027

6.6.1. Interdigital Tinea Pedis

6.6.2. Plantar Tinea Pedis

6.6.3. Vesicular Tinea Pedis

6.7. Historical Market Size (US$ Mn) Analysis By Drug Class, 2012-2016

6.7.1. Antifungals

6.7.2. Steroids and Anti-Infective Combinations

6.8. Market Size (US$ Mn) Forecast By Drug Class, 2017-2027

6.8.1. Antifungals

6.8.2. Steroids and Anti-Infective Combinations

6.9. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2012-2016

6.9.1. Topical

6.9.1.1. Gel

6.9.1.2. Cream

6.9.1.3. Spray

6.9.1.4. Lotion

6.9.1.5. Powder

6.9.2. Oral

6.10. Market Size (US$ Mn) Forecast By Route of Administration, 2017-2027

6.10.1. Topical

6.10.1.1. Gel

6.10.1.2. Cream

6.10.1.3. Spray

6.10.1.4. Lotion

6.10.1.5. Powder

6.10.2. Oral

6.11. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012-2016

6.11.1. Hospital Pharmacies

6.11.2. Retail Pharmacies

6.11.3. Drug Stores

6.11.4. Online Pharmacies

6.12. Market Size (US$ Mn) Forecast By Distribution Channel, 2017-2027

6.12.1. Hospital Pharmacies

6.12.2. Retail Pharmacies

6.12.3. Drug Stores

6.12.4. Online Pharmacies

6.13. Drivers and Restraints: Impact Analysis

6.14. Market Attractiveness Analysis

6.14.1. By Country

6.14.2. By Disease Type

6.14.3. By Drug Class

6.14.4. By Route of Administration

6.14.5. By Distribution Channel

7. Eastern Europe Tinea Pedis Treatment Market Analysis 2012–2016 and Forecast 2017–2027

7.1. Introduction

7.2. Regional Market Dynamics

7.2.1. Drivers

7.2.2. Restraints

7.2.3. Trends

7.3. Historical Market Size (US$ Mn) Analysis By Country, 2012–2016

7.3.1. Russia

7.3.2. Poland

7.3.3. Rest of Eastern Europe

7.4. Market Size (US$ Mn) Forecast By Country, 2017–2027

7.4.1. Russia

7.4.2. Poland

7.4.3. Rest of Eastern Europe

7.5. Historical Market Size (US$ Mn) Analysis By Disease Type, 2012-2016

7.5.1. Interdigital Tinea Pedis

7.5.2. Plantar Tinea Pedis

7.5.3. Vesicular Tinea Pedis

7.6. Market Size (US$ Mn) Forecast By Disease Type, 2017-2027

7.6.1. Interdigital Tinea Pedis

7.6.2. Plantar Tinea Pedis

7.6.3. Vesicular Tinea Pedis

7.7. Historical Market Size (US$ Mn) Analysis By Drug Class, 2012-2016

7.7.1. Antifungals

7.7.2. Steroids and Anti-Infective Combinations

7.8. Market Size (US$ Mn) Forecast By Drug Class, 2017-2027

7.8.1. Antifungals

7.8.2. Steroids and Anti-Infective Combinations

7.9. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2012-2016

7.9.1. Topical

7.9.1.1. Gel

7.9.1.2. Cream

7.9.1.3. Spray

7.9.1.4. Lotion

7.9.1.5. Powder

7.9.2. Oral

7.10. Market Size (US$ Mn) Forecast By Route of Administration, 2017-2027

7.10.1. Topical

7.10.1.1. Gel

7.10.1.2. Cream

7.10.1.3. Spray

7.10.1.4. Lotion

7.10.1.5. Powder

7.10.2. Oral

7.11. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012-2016

7.11.1. Hospital Pharmacies

7.11.2. Retail Pharmacies

7.11.3. Drug Stores

7.11.4. Online Pharmacies

7.12. Market Size (US$ Mn) Forecast By Distribution Channel, 2017-2027

7.12.1. Hospital Pharmacies

7.12.2. Retail Pharmacies

7.12.3. Drug Stores

7.12.4. Online Pharmacies

7.13. Drivers and Restraints: Impact Analysis

7.14. Market Attractiveness Analysis

7.14.1. By Country

7.14.2. By Disease Type

7.14.3. By Drug Class

7.14.4. By Route of Administration

7.14.5. By Distribution Channel

8. Asia Pacific excluding Japan Tinea Pedis Treatment Market Analysis 2012–2016 and Forecast 2017–2027

8.1. Introduction

8.2. Regional Market Dynamics

8.2.1. Drivers

8.2.2. Restraints

8.2.3. Trends

8.3. Historical Market Size (US$ Mn) Analysis By Country, 2012–2016

8.3.1. China

8.3.2. India

8.3.3. Australia and New Zealand

8.3.4. ASEAN

8.3.5. Rest of APEJ

8.4. Market Size (US$ Mn) Forecast By Country, 2017–2027

8.4.1. China

8.4.2. India

8.4.3. Australia and New Zealand

8.4.4. ASEAN

8.4.5. Rest of APEJ

8.5. Historical Market Size (US$ Mn) Analysis By Disease Type, 2012-2016

8.5.1. Interdigital Tinea Pedis

8.5.2. Plantar Tinea Pedis

8.5.3. Vesicular Tinea Pedis

8.6. Market Size (US$ Mn) Forecast By Disease Type, 2017-2027

8.6.1. Interdigital Tinea Pedis

8.6.2. Plantar Tinea Pedis

8.6.3. Vesicular Tinea Pedis

8.7. Historical Market Size (US$ Mn) Analysis By Drug Class, 2012-2016

8.7.1. Antifungals

8.7.2. Steroids and Anti-Infective Combinations

8.8. Market Size (US$ Mn) Forecast By Drug Class, 2017-2027

8.8.1. Antifungals

8.8.2. Steroids and Anti-Infective Combinations

8.9. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2012-2016

8.9.1. Topical

8.9.1.1. Gel

8.9.1.2. Cream

8.9.1.3. Spray

8.9.1.4. Lotion

8.9.1.5. Powder

8.9.2. Oral

8.10. Market Size (US$ Mn) Forecast By Route of Administration, 2017-2027

8.10.1. Topical

8.10.1.1. Gel

8.10.1.2. Cream

8.10.1.3. Spray

8.10.1.4. Lotion

8.10.1.5. Powder

8.10.2. Oral

8.11. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012-2016

8.11.1. Hospital Pharmacies

8.11.2. Retail Pharmacies

8.11.3. Drug Stores

8.11.4. Online Pharmacies

8.12. Market Size (US$ Mn) Forecast By Distribution Channel, 2017-2027

8.12.1. Hospital Pharmacies

8.12.2. Retail Pharmacies

8.12.3. Drug Stores

8.12.4. Online Pharmacies

8.13. Drivers and Restraints: Impact Analysis

8.14. Market Attractiveness Analysis

8.14.1. By Country

8.14.2. By Disease Type

8.14.3. By Drug Class

8.14.4. By Route of Administration

8.14.5. By Distribution Channel

9. Japan Tinea Pedis Treatment Market Analysis 2012–2016 and Forecast 2017–2027

9.1. Introduction

9.2. Regional Market Dynamics

9.2.1. Drivers

9.2.2. Restraints

9.2.3. Trends

9.3. Historical Market Size (US$ Mn) Analysis By Disease Type, 2012-2016

9.3.1. Interdigital Tinea Pedis

9.3.2. Plantar Tinea Pedis

9.3.3. Vesicular Tinea Pedis

9.4. Market Size (US$ Mn) Forecast By Disease Type, 2017-2027

9.4.1. Interdigital Tinea Pedis

9.4.2. Plantar Tinea Pedis

9.4.3. Vesicular Tinea Pedis

9.5. Historical Market Size (US$ Mn) Analysis By Drug Class, 2012-2016

9.5.1. Antifungals

9.5.2. Steroids and Anti-Infective Combinations

9.6. Market Size (US$ Mn) Forecast By Drug Class, 2017-2027

9.6.1. Antifungals

9.6.2. Steroids and Anti-Infective Combinations

9.7. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2012-2016

9.7.1. Topical

9.7.1.1. Gel

9.7.1.2. Cream

9.7.1.3. Spray

9.7.1.4. Lotion

9.7.1.5. Powder

9.7.2. Oral

9.8. Market Size (US$ Mn) Forecast By Route of Administration, 2017-2027

9.8.1. Topical

9.8.1.1. Gel

9.8.1.2. Cream

9.8.1.3. Spray

9.8.1.4. Lotion

9.8.1.5. Powder

9.8.2. Oral

9.9. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012-2016

9.9.1. Hospital Pharmacies

9.9.2. Retail Pharmacies

9.9.3. Drug Stores

9.9.4. Online Pharmacies

9.10. Market Size (US$ Mn) Forecast By Distribution Channel, 2017-2027

9.10.1. Hospital Pharmacies

9.10.2. Retail Pharmacies

9.10.3. Drug Stores

9.10.4. Online Pharmacies

9.11. Drivers and Restraints: Impact Analysis

9.12. Market Attractiveness Analysis

9.12.1. By Disease Type

9.12.2. By Drug Class

9.12.3. By Route of Administration

9.12.4. By Distribution Channel

10. Middle East & Africa Tinea Pedis Treatment Market Analysis 2012–2016 and Forecast 2017–2027

10.1. Introduction

10.2. Regional Market Dynamics

10.2.1. Drivers

10.2.2. Restraints

10.2.3. Trends

10.3. Historical Market Size (US$ Mn) Analysis By Country, 2012–2016

10.3.1. GCC Countries

10.3.2. South Africa

10.3.3. Rest of MEA

10.4. Market Size (US$ Mn) Forecast By Country, 2017–2027

10.4.1. GCC Countries

10.4.2. South Africa

10.4.3. Rest of MEA

10.5. Historical Market Size (US$ Mn) Analysis By Disease Type, 2012-2016

10.5.1. Interdigital Tinea Pedis

10.5.2. Plantar Tinea Pedis

10.5.3. Vesicular Tinea Pedis

10.6. Market Size (US$ Mn) Forecast By Disease Type, 2017-2027

10.6.1. Interdigital Tinea Pedis

10.6.2. Plantar Tinea Pedis

10.6.3. Vesicular Tinea Pedis

10.7. Historical Market Size (US$ Mn) Analysis By Drug Class, 2012-2016

10.7.1. Antifungals

10.7.2. Steroids and Anti-Infective Combinations

10.8. Market Size (US$ Mn) Forecast By Drug Class, 2017-2027

10.8.1. Antifungals

10.8.2. Steroids and Anti-Infective Combinations

10.9. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2012-2016

10.9.1. Topical

10.9.1.1. Gel

10.9.1.2. Cream

10.9.1.3. Spray

10.9.1.4. Lotion

10.9.1.5. Powder

10.9.2. Oral

10.10. Market Size (US$ Mn) Forecast By Route of Administration, 2017-2027

10.10.1. Topical

10.10.1.1. Gel

10.10.1.2. Cream

10.10.1.3. Spray

10.10.1.4. Lotion

10.10.1.5. Powder

10.10.2. Oral

10.11. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012-2016

10.11.1. Hospital Pharmacies

10.11.2. Retail Pharmacies

10.11.3. Drug Stores

10.11.4. Online Pharmacies

10.12. Market Size (US$ Mn) Forecast By Distribution Channel, 2017-2027

10.12.1. Hospital Pharmacies

10.12.2. Retail Pharmacies

10.12.3. Drug Stores

10.12.4. Online Pharmacies

10.13. Drivers and Restraints: Impact Analysis

10.14. Market Attractiveness Analysis

10.14.1. By Country

10.14.2. By Disease Type

10.14.3. By Drug Class

10.14.4. By Route of Administration

10.14.5. By Distribution Channel

11. Forecast Factors: Relevance and Impact

12. Forecast Assumptions

13. Competition Landscape

13.1. Competition Dashboard

13.2. Company Profiles (Details – Overview, Financials, Strategy, SWOT, Recent Developments)

13.2.1. Perrigo Company

13.2.2. Taro Pharmaceuticals U.S.A., Inc.

13.2.3. Teva Pharmaceuticals, Inc.

13.2.4. Glenmark Pharmaceuticals Inc., USA

13.2.5. Breckenridge Pharmaceutical, Inc.

13.2.6. NorthStar Rx LLC

13.2.7. Aurobindo Pharma Limited

13.2.8. Camber Pharmaceuticals, Inc.

13.2.9. AvKare, Inc.

13.2.10. Novartis AG

13.2.11. Sebela Pharmaceuticals, Inc.

13.2.12. Bayer AG

13.2.13. Blueberry Therapeutics Ltd.

13.2.14. GlaxoSmithKline plc.

13.2.15. Exeltis USA

13.2.16. Valeant Pharmaceuticals, Inc.

13.2.17. CorePharma, LLC

13.2.18. McNeil Consumer Healthcare

13.2.19. Aqua Pharmaceuticals LLC

13.2.20. Mylan N.V.

14. Global Tinea Pedis Treatment Market Analysis 2012–2016 and Forecast 2017–2027, By Region

14.1. Introduction/Key Findings

14.2. Historical Market Size (US$ Mn) Trend Analysis By Region, 2012–2016

14.2.1. North America

14.2.2. Latin America

14.2.3. Western Europe

14.2.4. Eastern Europe

14.2.5. Asia Pacific excluding Japan

14.2.6. Japan

14.2.7. Middle East & Africa

14.3. Market Size (US$ Mn) Forecast By Region, 2017–2027

14.3.1. North America

14.3.2. Latin America

14.3.3. Western Europe

14.3.4. Eastern Europe

14.3.5. Asia Pacific excluding Japan

14.3.6. Japan

14.3.7. Middle East & Africa

14.4. Market Attractiveness Analysis By Region

15. Global Tinea Pedis Treatment Market Analysis 2012–2016 and Forecast 2017–2027, By Disease Type

15.1. Introduction/Key Findings

15.2. Historical Market Size (US$ Mn) Trend Analysis By Disease Type, 2012–2016

15.2.1. Interdigital Tinea Pedis

15.2.2. Plantar Tinea Pedis

15.2.3. Vesicular Tinea Pedis

15.3. Market Size (US$ Mn) Forecast By Disease Type, 2017–2027

15.3.1. Interdigital Tinea Pedis

15.3.2. Plantar Tinea Pedis

15.3.3. Vesicular Tinea Pedis

15.4. Market Attractiveness Analysis By Disease Type

16. Global Tinea Pedis Treatment Market Analysis 2012–2016 and Forecast 2017–2027, By Drug Class

16.1. Introduction/Key Findings

16.2. Historical Market Size (US$ Mn) Trend Analysis By Drug Class, 2012–2016

16.2.1. Antifungals

16.2.2. Steroids and Anti-Infective Combinations

16.3. Market Size (US$ Mn) Forecast By Drug Class, 2017–2027

16.3.1. Antifungals

16.3.2. Steroids and Anti-Infective Combinations

16.4. Market Attractiveness Analysis By Drug Class

17. Global Tinea Pedis Treatment Market Analysis 2012–2016 and Forecast 2017–2027, By Route of Administration 

17.1. Introduction/Key Findings

17.2. Historical Market Size (US$ Mn) Trend Analysis By Route of Administration, 2012–2016

17.2.1. Topical

17.2.1.1. Gel

17.2.1.2. Cream

17.2.1.3. Spray

17.2.1.4. Lotion

17.2.1.5. Powder

17.2.2. Oral

17.3. Market Size (US$ Mn) Forecast By Route of Administration, 2017–2027

17.3.1. Topical

17.3.1.1. Gel

17.3.1.2. Cream

17.3.1.3. Spray

17.3.1.4. Lotion

17.3.1.5. Powder

17.3.2. Oral

17.4. Market Attractiveness Analysis By Route of Administration

18. Global Tinea Pedis Treatment Market Analysis 2012–2016 and Forecast 2017–2027, By Distribution Channel 

18.1. Introduction/Key Findings

18.2. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2012–2016

18.2.1. Hospital Pharmacies

18.2.2. Retail Pharmacies

18.2.3. Drug Stores

18.2.4. Online Pharmacies

18.3. Market Size (US$ Mn) Forecast By Distribution Channel, 2017–2027

18.3.1. Hospital Pharmacies

18.3.2. Retail Pharmacies

18.3.3. Drug Stores

18.3.4. Online Pharmacies

18.4. Market Attractiveness Analysis By Distribution Channel

19. Global Tinea Pedis Treatment Market Analysis 2012–2016 and Forecast 2017–2027

19.1. Market Size and Y-o-Y Growth

19.2. Absolute $ Opportunity

19.3 Market Value Chain

Tinea Pedis Treatment Market Reports - List of Tables

Table 01: AntiFungals and their usual concentrations

Table 2: North America Tinea Pedis Treatments Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Country

Table 3: North America Tinea Pedis Treatments Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Disease Type

Table 4: North America Tinea Pedis Treatments Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Drug Class

Table 5: North America Tinea Pedis Treatments Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Route of Administration

Table 6: North America Tinea Pedis Treatments Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Distribution Channel

Table 7: Latin America Tinea Pedis Treatments Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Country

Table 8: Latin America Tinea Pedis Treatments Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Disease Type

Table 9: Latin America Tinea Pedis Treatments Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Drug Class

Table 10: Latin America Tinea Pedis Treatments Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Route of Administration

Table 11: Latin America Tinea Pedis Treatments Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Distribution Channel

Table 12: Western Europe Tinea Pedis Treatments Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Country

Table 13: Western Europe Tinea Pedis Treatments Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Disease Type

Table 14: Western Europe Tinea Pedis Treatments Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Drug Class

Table 15: Western Europe Tinea Pedis Treatments Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Route of Administration

Table 16: Western Europe Tinea Pedis Treatments Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Distribution Channel

Table 17: Eastern Europe Tinea Pedis Treatments Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Country

Table 18: Eastern Europe Tinea Pedis Treatments Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Disease Type

Table 19: Eastern Europe Tinea Pedis Treatments Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Drug Class

Table 20: Eastern Europe Tinea Pedis Treatments Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Route of Administration

Table 21: Eastern Europe Tinea Pedis Treatments Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Distribution Channel

Table 22: APEJ Tinea Pedis Treatments Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Country

Table 23: APEJ Tinea Pedis Treatments Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Disease Type

Table 24: APEJ Tinea Pedis Treatments Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Drug Class

Table 25: APEJ Tinea Pedis Treatments Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Route of Administration

Table 26: APEJ Tinea Pedis Treatments Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Distribution Channel

Table 27: Japan Tinea Pedis Treatments Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Disease Type

Table 28: Japan Tinea Pedis Treatments Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Drug Class

Table 29: Japan Tinea Pedis Treatments Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Route of Administration

Table 30: Japan Tinea Pedis Treatments Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Distribution Channel

Table 31: MEA Tinea Pedis Treatments Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Country

Table 32: MEA Tinea Pedis Treatments Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Disease Type

Table 33: MEA Tinea Pedis Treatments Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Drug Class

Table 34: MEA Tinea Pedis Treatments Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Route of Administration

Table 35: MEA Tinea Pedis Treatments Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Distribution Channel

Table 36: North America Tinea Pedis Treatments Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Region

Table 37: Global Tinea Pedis Treatments Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Disease Type

Table 38: Global Tinea Pedis Treatments Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Drug Class

Table 39: Global Tinea Pedis Treatments Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Route of Administration

Table 40: Global Tinea Pedis Treatments Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Distribution Channel

Tinea Pedis Treatment Market Reports - List of Figures

Figure 01: GDP (US$ Trillion) and Healthcare Expenditure % (2014)

Figure 02: Economic and Clinical Value Measures in Pricing of Therapies

Figure 03: North America Tinea Pedis Treatment Market Value Share (2017)

Figure 04: North America Tinea Pedis Treatment Market Value Share (2017), By Country

Figure 05: Prevalence of Tinea Infection in North America

Figure 06: North America Tinea Pedis Treatment Market Size (US$ Mn) Analysis, 2012–2016,

Figure 07: North America Tinea Pedis Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027

Figure 08: North America Tinea Pedis Treatments Market Size (US$ Mn) Analysis, 2012–2016, By Interdigital Tinea Pedis

Figure 09: North America Tinea Pedis Treatments Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, By Interdigital Tinea Pedis

Figure 10: North America Tinea Pedis Treatments Market Size (US$ Mn) Analysis, 2012–2016, By Plantar Tinea Pedis

Figure 11: North America Tinea Pedis Treatments Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, By Plantar Tinea Pedis

Figure 12: North America Tinea Pedis Treatment Market Size (US$ Mn) Analysis, 2012–2016, By Vesicular Tinea Pedis

Figure 13: North America Tinea Pedis Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, By Vesicular Tinea Pedis

Figure 14: North America Tinea Pedis Treatments Market Size (US$ Mn) Analysis, 2012–2016, By Antifungals

Figure 15: North America Tinea Pedis Treatments Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, By Antifungals

Figure 16: North America Tinea Pedis Treatments Market Size (US$ Mn) Analysis, 2012–2016, By Steroids and Anti-Infective Combinations

Figure 17: North America Tinea Pedis Treatments Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, By Steroids and Anti-Infective Combinations

Figure 18: North America Tinea Pedis Treatments Market Size (US$ Mn) Analysis, 2012–2016, By Topical

Figure 19: North America Tinea Pedis Treatments Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, By Topical

Figure 20: North America Tinea Pedis Treatments Market Size (US$ Mn) Analysis, 2012–2016, By Oral

Figure 21: North America Tinea Pedis Treatments Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, By Oral

Figure 22: North America Tinea Pedis Treatment Market Size (US$ Mn) Analysis, 2012–2016, By Hospital Pharmacy

Figure 23: North America Tinea Pedis Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, By Hospital Pharmacy

Figure 24: North America Tinea Pedis Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2026, By Retail Pharmacy

Figure 25: North America Tinea Pedis Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, By Retail Pharmacy

Figure 26: North America Tinea Pedis Treatment Market Size (US$ Mn) Analysis, 2012–2016, By Drug Stores

Figure 27: North America Tinea Pedis Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, By Drug Stores

Figure 28: North America Tinea Pedis Treatment Market Size (US$ Mn) Analysis, 2012–2016, By Online Pharmacy

Figure 29: North America Tinea Pedis Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, By Online Pharmacy

Figure 30: North America Tinea Pedis Treatments Market Attractiveness Analysis, , By Disease Type

Figure 31: North America Tinea Pedis Treatments Market Attractiveness Analysis, By Drug Class

Figure 32: North America Tinea Pedis Treatments Market Attractiveness Analysis, By Country

Figure 33: North America Tinea Pedis Treatments Market Attractiveness Analysis, By Route of Administration

Figure 34: North America Tinea Pedis Treatments Market Attractiveness Analysis, By Distribution Channel

Figure 35: Latin America Tinea Pedis Treatment Market Value Share (2017)

Figure 36: Latin America Tinea Pedis Treatment Market Value Share (2017), By Country

Figure 37: Latin America Tinea Pedis Treatment Market Size (US$ Mn) Analysis, 2012–2016,

Figure 38: Latin America Tinea Pedis Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027

Figure 39: Latin America Tinea Pedis Treatments Market Size (US$ Mn) Analysis, 2012–2016, By Interdigital Tinea Pedis

Figure 41: Latin America Tinea Pedis Treatments Market Size (US$ Mn) Analysis, 2012–2016, By Plantar Tinea Pedis

Figure 40: Latin America Tinea Pedis Treatments Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, By Interdigital Tinea Pedis

Figure 42: Latin America Tinea Pedis Treatments Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, By Plantar Tinea Pedis

Figure 43: Latin America Tinea Pedis Treatment Market Size (US$ Mn) Analysis, 2012–2016, By Vesicular Tinea Pedis

Figure 44: Latin America Tinea Pedis Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, By Vesicular Tinea Pedis

Figure 45: Latin America Tinea Pedis Treatments Market Size (US$ Mn) Analysis, 2012–2016, By Antifungals

Figure 46: Latin America Tinea Pedis Treatments Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, By Antifungals

Figure 47: Latin America Tinea Pedis Treatments Market Size (US$ Mn) Analysis, 2012–2016, By Steroids and Anti-Infective Combinations

Figure 48: Latin America Tinea Pedis Treatments Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, By Steroids and Anti-Infective Combinations

Figure 49: Latin America Tinea Pedis Treatments Market Size (US$ Mn) Analysis, 2012–2016, By Topical

Figure 50: Latin America Tinea Pedis Treatments Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, By Topical

Figure 51: Latin America Tinea Pedis Treatments Market Size (US$ Mn) Analysis, 2012–2016, By Oral

Figure 52: Latin America Tinea Pedis Treatments Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, By Oral

Figure 53: Latin America Tinea Pedis Treatment Market Size (US$ Mn) Analysis, 2012–2016, By Hospital Pharmacy

Figure 54: Latin America Tinea Pedis Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, By Hospital Pharmacy

Figure 55: Latin America Tinea Pedis Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2026, By Retail Pharmacy

Figure 56: Latin America Tinea Pedis Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, By Retail Pharmacy

Figure 57: Latin America Tinea Pedis Treatment Market Size (US$ Mn) Analysis, 2012–2016, By Drug Stores

Figure 58: Latin America Tinea Pedis Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, By Drug Stores

Figure 59: Latin America Tinea Pedis Treatment Market Size (US$ Mn) Analysis, 2012–2016, By Online Pharmacy

Figure 60: Latin America Tinea Pedis Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, By Online Pharmacy

Figure 61: Latin America Tinea Pedis Treatments Market Attractiveness Analysis, , By Disease Type

Figure 62: Latin America Tinea Pedis Treatments Market Attractiveness Analysis, By Drug Class

Figure 63: Latin America Tinea Pedis Treatments Market Attractiveness Analysis, By Country

Figure 64: Latin America Tinea Pedis Treatments Market Attractiveness Analysis, By Route of Administration

Figure 65: Latin America Tinea Pedis Treatments Market Attractiveness Analysis, By Distribution Channel

Figure 66: Western Europe Tinea Pedis Treatment Market Value Share (2017)

Figure 67: Western Europe Tinea Pedis Treatment Market Value Share (2017), By Country

Figure 68: Western Europe Tinea Pedis Treatment Market Size (US$ Mn) Analysis, 2012–2016,

Figure 69: Western Europe Tinea Pedis Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027

Figure 70: Adult Population (20-79) in 1000s, 2013 (Europe)

Figure 71: Western Europe Tinea Pedis Treatments Market Size (US$ Mn) Analysis, 2012–2016, By Interdigital Tinea Pedis

Figure 72: Western Europe Tinea Pedis Treatments Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, By Interdigital Tinea Pedis

Figure 73: Western Europe Tinea Pedis Treatments Market Size (US$ Mn) Analysis, 2012–2016, By Plantar Tinea Pedis

Figure 74: Western Europe Tinea Pedis Treatments Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, By Plantar Tinea Pedis

Figure 75: Western Europe Tinea Pedis Treatment Market Size (US$ Mn) Analysis, 2012–2016, By Vesicular Tinea Pedis

Figure 76: Western Europe Tinea Pedis Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, By Vesicular Tinea Pedis

Figure 77: Western Europe Tinea Pedis Treatments Market Size (US$ Mn) Analysis, 2012–2016, By Antifungals

Figure 78: Western Europe Tinea Pedis Treatments Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, By Antifungals

Figure 79: Western Europe Tinea Pedis Treatments Market Size (US$ Mn) Analysis, 2012–2016, By Steroids and Anti-Infective Combinations

Figure 80: Western Europe Tinea Pedis Treatments Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, By Steroids and Anti-Infective Combinations

Figure 81: Western Europe Tinea Pedis Treatments Market Size (US$ Mn) Analysis, 2012–2016, By Topical

Figure 82: Western Europe Tinea Pedis Treatments Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, By Topical

Figure 83: Western Europe Tinea Pedis Treatments Market Size (US$ Mn) Analysis, 2012–2016, By Oral

Figure 84: Western Europe Tinea Pedis Treatments Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, By Oral

Figure 85: Western Europe Tinea Pedis Treatment Market Size (US$ Mn) Analysis, 2012–2016, By Hospital Pharmacy

Figure 86: Western Europe Tinea Pedis Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, By Hospital Pharmacy

Figure 87: Western Europe Tinea Pedis Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2026, By Retail Pharmacy

Figure 88: Western Europe Tinea Pedis Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, By Retail Pharmacy

Figure 89: Western Europe Tinea Pedis Treatment Market Size (US$ Mn) Analysis, 2012–2016, By Drug Stores

Figure 91: Western Europe Tinea Pedis Treatment Market Size (US$ Mn) Analysis, 2012–2016, By Online Pharmacy

Figure 90: Western Europe Tinea Pedis Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, By Drug Stores

Figure 92: Western Europe Tinea Pedis Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, By Online Pharmacy

Figure 93: Western Europe Tinea Pedis Treatments Market Attractiveness Analysis, , By Disease Type

Figure 96: Western Europe Tinea Pedis Treatments Market Attractiveness Analysis, By Route of Administration

Figure 94: Western Europe Tinea Pedis Treatments Market Attractiveness Analysis, By Drug Class

Figure 95: Western Europe Tinea Pedis Treatments Market Attractiveness Analysis, By Country

Figure 96: Western Europe Tinea Pedis Treatments Market Attractiveness Analysis, By Route of Administration

Figure 97: Western Europe Tinea Pedis Treatments Market Attractiveness Analysis, By Distribution Channel

Figure 98: Eastern Europe Tinea Pedis Treatment Market Value Share (2017)

Figure 99: Eastern Europe Tinea Pedis Treatment Market Value Share (2017), By Country

Figure 100: Eastern Europe Tinea Pedis Treatment Market Size (US$ Mn) Analysis, 2012–2016,

Figure 101: Eastern Europe Tinea Pedis Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027

Figure 102: Eastern Europe Tinea Pedis Treatments Market Size (US$ Mn) Analysis, 2012–2016, By Interdigital Tinea Pedis

Figure 103: Eastern Europe Tinea Pedis Treatments Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, By Interdigital Tinea Pedis

Figure 104: Eastern Europe Tinea Pedis Treatments Market Size (US$ Mn) Analysis, 2012–2016, By Plantar Tinea Pedis

Figure 105: Eastern Europe Tinea Pedis Treatments Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, By Plantar Tinea Pedis

Figure 106: Eastern Europe Tinea Pedis Treatment Market Size (US$ Mn) Analysis, 2012–2016, By Vesicular Tinea Pedis

Figure 107: Eastern Europe Tinea Pedis Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, By Vesicular Tinea Pedis

Figure 108: Eastern Europe Tinea Pedis Treatments Market Size (US$ Mn) Analysis, 2012–2016, By Antifungals

Figure 109: Eastern Europe Tinea Pedis Treatments Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, By Antifungals

Figure 110: Eastern Europe Tinea Pedis Treatments Market Size (US$ Mn) Analysis, 2012–2016, By Steroids and Anti-Infective Combinations

Figure 111: Eastern Europe Tinea Pedis Treatments Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, By Steroids and Anti-Infective Combinations

Figure 112: Eastern Europe Tinea Pedis Treatments Market Size (US$ Mn) Analysis, 2012–2016, By Topical

Figure 113: Eastern Europe Tinea Pedis Treatments Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, By Topical

Figure 114: Eastern Europe Tinea Pedis Treatments Market Size (US$ Mn) Analysis, 2012–2016, By Oral

Figure 115: Eastern Europe Tinea Pedis Treatments Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, By Oral

Figure 116: Eastern Europe Tinea Pedis Treatment Market Size (US$ Mn) Analysis, 2012–2016, By Hospital Pharmacy

Figure 117: Eastern Europe Tinea Pedis Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, By Hospital Pharmacy

Figure 118: Western Europe Tinea Pedis Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2026, By Retail Pharmacy

Figure 119: Eastern Europe Tinea Pedis Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, By Retail Pharmacy

Figure 120: Eastern Europe Tinea Pedis Treatment Market Size (US$ Mn) Analysis, 2012–2016, By Drug Stores

Figure 121: Eastern Europe Tinea Pedis Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, By Drug Stores

Figure 122: Eastern Europe Tinea Pedis Treatment Market Size (US$ Mn) Analysis, 2012–2016, By Online Pharmacy

Figure 123: Eastern Europe Tinea Pedis Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, By Online Pharmacy

Figure 124: Eastern Europe Tinea Pedis Treatments Market Attractiveness Analysis, , By Disease Type

Figure 125: Eastern Europe Tinea Pedis Treatments Market Attractiveness Analysis, By Drug Class

Figure 126: Eastern Europe Tinea Pedis Treatments Market Attractiveness Analysis, By Country

Figure 127: Eastern Europe Tinea Pedis Treatments Market Attractiveness Analysis, By Route of Administration

Figure 128: Eastern Europe Tinea Pedis Treatments Market Attractiveness Analysis, By Distribution Channel

Figure 129: APEJ Tinea Pedis Treatment Market Value Share (2017)

Figure 130: APEJ Tinea Pedis Treatment Market Value Share (2017), By Country

Figure 131: APEJ Tinea Pedis Treatment Market Size (US$ Mn) Analysis, 2012–2016,

Figure 132: APEJ Tinea Pedis Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027

Figure 133: APEJ Tinea Pedis Treatments Market Size (US$ Mn) Analysis, 2012–2016, By Interdigital Tinea Pedis

Figure 134: APEJ Tinea Pedis Treatments Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, By Interdigital Tinea Pedis

Figure 135: APEJ Tinea Pedis Treatments Market Size (US$ Mn) Analysis, 2012–2016, By Plantar Tinea Pedis

Figure 136: APEJ Tinea Pedis Treatments Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, By Plantar Tinea Pedis

Figure 137: APEJ Tinea Pedis Treatment Market Size (US$ Mn) Analysis, 2012–2016, By Vesicular Tinea Pedis

Figure 138: APEJ Tinea Pedis Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, By Vesicular Tinea Pedis

Figure 139: APEJ Tinea Pedis Treatments Market Size (US$ Mn) Analysis, 2012–2016, By Antifungals

Figure 140: APEJ Tinea Pedis Treatments Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, By Antifungals

Figure 141: APEJ Tinea Pedis Treatments Market Size (US$ Mn) Analysis, 2012–2016, By Steroids and Anti-Infective Combinations

Figure 142: APEJ Tinea Pedis Treatments Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, By Steroids and Anti-Infective Combinations

Figure 143: APEJ Tinea Pedis Treatments Market Size (US$ Mn) Analysis, 2012–2016, By Topical

Figure 144: APEJ Tinea Pedis Treatments Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, By Topical

Figure 145: APEJ Tinea Pedis Treatments Market Size (US$ Mn) Analysis, 2012–2016, By Oral

Figure 146: APEJ Tinea Pedis Treatments Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, By Oral

Figure 147: APEJ Tinea Pedis Treatment Market Size (US$ Mn) Analysis, 2012–2016, By Hospital Pharmacy

Figure 148: APEJ Tinea Pedis Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, By Hospital Pharmacy

Figure 149: APEJ Tinea Pedis Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2026, By Retail Pharmacy

Figure 150: APEJ Tinea Pedis Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, By Retail Pharmacy

Figure 151: APEJ Tinea Pedis Treatment Market Size (US$ Mn) Analysis, 2012–2016, By Drug Stores

Figure 152: APEJ Tinea Pedis Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, By Drug Stores

Figure 153: APEJ Tinea Pedis Treatment Market Size (US$ Mn) Analysis, 2012–2016, By Online Pharmacy

Figure 154: APEJ Tinea Pedis Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, By Online Pharmacy

Figure 155: APEJ Tinea Pedis Treatments Market Attractiveness Analysis, , By Disease Type

Figure 156: APEJ Tinea Pedis Treatments Market Attractiveness Analysis, By Drug Class

Figure 157: APEJ Tinea Pedis Treatments Market Attractiveness Analysis, By Country

Figure 158: APEJ Tinea Pedis Treatments Market Attractiveness Analysis, By Route of Administration

Figure 159: APEJ Tinea Pedis Treatments Market Attractiveness Analysis, By Distribution Channel

Figure 160: Japan Tinea Pedis Treatment Market Value Share (2017) distribution channel over 2017–2027

Figure 161: Japan Tinea Pedis Treatment Market Value 2017- 2027 (US$ Mn)

Figure 162: Japan Tinea Pedis Treatment Market Size (US$ Mn) Analysis, 2012–2016,

Figure 163: Japan Tinea Pedis Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027

Figure 164: Total burden of fungal infections estimated in Japan, 2011

Figure 165: Japan Tinea Pedis Treatments Market Size (US$ Mn) Analysis, 2012–2016, By Interdigital Tinea Pedis

Figure 166: Japan Tinea Pedis Treatments Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, By Interdigital Tinea Pedis

Figure 167: Japan Tinea Pedis Treatments Market Size (US$ Mn) Analysis, 2012–2016, By Plantar Tinea Pedis

Figure 168: Japan Tinea Pedis Treatments Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, By Plantar Tinea Pedis

Figure 169: Japan Tinea Pedis Treatment Market Size (US$ Mn) Analysis, 2012–2016, By Vesicular Tinea Pedis

Figure 170: Japan Tinea Pedis Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, By Vesicular Tinea Pedis

Figure 171: Japan Tinea Pedis Treatments Market Size (US$ Mn) Analysis, 2012–2016, By Antifungals

Figure 172: Japan Tinea Pedis Treatments Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, By Antifungals

Figure 173: Japan Tinea Pedis Treatments Market Size (US$ Mn) Analysis, 2012–2016, By Steroids and Anti-Infective Combinations

Figure 174: Japan Tinea Pedis Treatments Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, By Steroids and Anti-Infective Combinations

Figure 175: Japan Tinea Pedis Treatments Market Size (US$ Mn) Analysis, 2012–2016, By Topical

Figure 176: Japan Tinea Pedis Treatments Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, By Topical

Figure 177: Japan Tinea Pedis Treatments Market Size (US$ Mn) Analysis, 2012–2016, By Oral

Figure 178: Japan Tinea Pedis Treatments Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, By Oral

Figure 179: Japan Tinea Pedis Treatment Market Size (US$ Mn) Analysis, 2012–2016, By Hospital Pharmacy

Figure 180: Japan Tinea Pedis Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, By Hospital Pharmacy

Figure 181: Japan Tinea Pedis Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2026, By Retail Pharmacy

Figure 182: Japan Tinea Pedis Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, By Retail Pharmacy

Figure 183: Japan Tinea Pedis Treatment Market Size (US$ Mn) Analysis, 2012–2016, By Drug Stores

Figure 184: Japan Tinea Pedis Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, By Drug Stores

Figure 185: Japan Tinea Pedis Treatment Market Size (US$ Mn) Analysis, 2012–2016, By Online Pharmacy

Figure 186: Japan Tinea Pedis Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, By Online Pharmacy

Figure 187: Japan Tinea Pedis Treatments Market Attractiveness Analysis, By Disease Type

Figure 188: Japan Tinea Pedis Treatments Market Attractiveness Analysis, By Drug Class

Figure 189: Japan Tinea Pedis Treatments Market Attractiveness Analysis, By Route of Administration 

Figure 190: Japan Tinea Pedis Treatments Market Attractiveness Analysis, By Distribution Channel

Figure 191: MEA Tinea Pedis Treatment Market Value Share (2017)

Figure 192: MEA Tinea Pedis Treatment Market Value Share (2017), By Country

Figure 193: MEA Tinea Pedis Treatment Market Size (US$ Mn) Analysis, 2012–2016,

Figure 194: MEA Tinea Pedis Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027

Figure 195: MEA Tinea Pedis Treatments Market Size (US$ Mn) Analysis, 2012–2016, By Interdigital Tinea Pedis

Figure 196: MEA Tinea Pedis Treatments Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, By Interdigital Tinea Pedis

Figure 197: MEA Tinea Pedis Treatments Market Size (US$ Mn) Analysis, 2012–2016, By Plantar Tinea Pedis

Figure 198: MEA Tinea Pedis Treatments Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, By Plantar Tinea Pedis

Figure 199: MEA Tinea Pedis Treatment Market Size (US$ Mn) Analysis, 2012–2016, By Vesicular Tinea Pedis

Figure 200: MEA Tinea Pedis Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, By Vesicular Tinea Pedis

Figure 201: MEA Tinea Pedis Treatments Market Size (US$ Mn) Analysis, 2012–2016, By Antifungals

Figure 202: MEA Tinea Pedis Treatments Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, By Antifungals

Figure 203: MEA Tinea Pedis Treatments Market Size (US$ Mn) Analysis, 2012–2016, By Steroids and Anti-Infective Combinations

Figure 204: MEA Tinea Pedis Treatments Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, By Steroids and Anti-Infective Combinations

Figure 205: MEA Tinea Pedis Treatments Market Size (US$ Mn) Analysis, 2012–2016, By Topical

Figure 206: MEA Tinea Pedis Treatments Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, By Topical

Figure 207: MEA Tinea Pedis Treatments Market Size (US$ Mn) Analysis, 2012–2016, By Oral

Figure 208: MEA Tinea Pedis Treatments Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, By Oral

Figure 209: MEA Tinea Pedis Treatment Market Size (US$ Mn) Analysis, 2012–2016, By Hospital Pharmacy

Figure 210: MEA Tinea Pedis Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, By Hospital Pharmacy

Figure 211: MEA Tinea Pedis Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2026, By Retail Pharmacy

Figure 212: MEA Tinea Pedis Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, By Retail Pharmacy

Figure 213: MEA Tinea Pedis Treatment Market Size (US$ Mn) Analysis, 2012–2016, By Drug Stores

Figure 214: MEA Tinea Pedis Treatment Market Size (US$ Mn) Analysis, 2012–2016, By Online Pharmacy

Figure 215: MEA Tinea Pedis Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, By Drug Stores

Figure 216: MEA Tinea Pedis Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, By Online Pharmacy

Figure 217: MEA Tinea Pedis Treatments Market Attractiveness Analysis, , By Disease Type

Figure 218: MEA Tinea Pedis Treatments Market Attractiveness Analysis, By Drug Class

Figure 219: MEA Tinea Pedis Treatments Market Attractiveness Analysis, By Country

Figure 220: MEA Tinea Pedis Treatments Market Attractiveness Analysis, By Route of Administration

Figure 221: MEA Tinea Pedis Treatments Market Attractiveness Analysis, By Distribution Channel

Figure 222: Global Tinea Pedis Treatment Market Attractiveness Analysis, By Region

Figure 223: Global Tinea Pedis Treatment Market Attractiveness Analysis, By Disease Type

Figure 224: Global Tinea Pedis Treatment Market Attractiveness Analysis, By Drug Class

Figure 225: Global Tinea Pedis Treatment Market Attractiveness Analysis, By Route of Administration

Figure 226: Global Tinea Pedis Treatment Market Attractiveness Analysis, By Distribution Channel

Figure 227: Global Tinea Pedis Treatment Historical Market Size and Y-o-Y, 2012 - 2016

Figure 228: Global Tinea Pedis Treatment Projected Market Size (US$ Mn) and Y-o-Y, 2017 - 2027

Figure 229: Global Tinea Pedis Treatment Market Absolute $ Opportunity, 2012–2027